Results 211 to 220 of about 25,852 (227)

Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy

British Journal of Clinical Pharmacology, 2010
Christa E Nath, Peter J Shaw, Judith Trotman   +2 more
exaly  

Hydrolysis and Protein Binding of Melphalan

Journal of Pharmaceutical Sciences, 1978
S Y Chang, D S Alberts, D Farquhar
exaly  

Synergistic inhibition of malignant melanoma proliferation by melphalan combined with ultrasound and microbubbles

Ultrasonics Sonochemistry, 2011
Kazuki Yamaguchi, Katsuro Tachibana
exaly  

Degradation of Melphalan in Aqueous Solutions—Influence of Human Albumin Binding

Journal of Pharmaceutical Sciences, 1982
Hans Ehrsson
exaly  

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

British Journal of Cancer, 2000
J H W De Wilt, T L M Ten Hagen, Sandra T Van Tiel   +2 more
exaly  

Melphalan

2011
openaire   +1 more source

High-Pressure Liquid Chromatographic Analysis of Melphalan in Plasma

Journal of Pharmaceutical Sciences, 1978
S Y Chang, D S Alberts, Sydney E Salmon
exaly  

Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- α versus toxicity after melphalan alone

European Journal of Surgical Oncology, 2001
A M M Eggermont, A N Van Geel, Omgo E Nieweg   +2 more
exaly  

Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipients

British Journal of Clinical Pharmacology, 2007
Christa E Nath, Peter J Shaw
exaly  

Melphalan

Reactions Weekly, 2012
openaire   +1 more source